Skip to main content

CARACTERIZACION DE LA FIRMA MICROBIANA ASOCIADA A LA ENFERMEDAD CELIACA. IMPACTO DE LA DIETA EN LA INMUNOGENICIDAD DEL GLUTEN.

PID2020-119044GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Modeling Dynamics of Human Gut Microbiota Derived from Gluten Metabolism: Obtention, Maintenance and Characterization of Complex Microbial Communities

  • Carnicero Mayo, Yaiza
  • Sáenz de Miera Carnicer, Luis Enrique
  • Ferrero García, Miguel Ángel
  • Navasa Mayo, Nicolás
  • Casqueiro Blanco, Francisco Javier
[EN] Western diets are rich in gluten-containing products, which are frequently poorly digested. The human large intestine harbors microorganisms able to metabolize undigested gluten fragments that have escaped digestion by human enzymatic activities. The aim of this work was obtaining and culturing complex human gut microbial communities derived from gluten metabolism to model the dynamics of healthy human large intestine microbiota associated with different gluten forms. For this purpose, stool samples from six healthy volunteers were inoculated in media containing predigested gluten or predigested gluten plus non-digested gluten. Passages were carried out every 24 h for 15 days in the same medium and community composition along time was studied via V3–V4 16S rDNA sequencing. Diverse microbial communities were successfully obtained. Moreover, communities were shown to be maintained in culture with stable composition for 14 days. Under non-digested gluten presence, communities were enriched in members of Bacillota, such as Lachnospiraceae, Clostridiaceae, Streptococcaceae, Peptoniphilaceae, Selenomonadaceae or Erysipelotrichaceae, and members of Actinomycetota, such as Bifidobacteriaceae and Eggerthellaceae. Contrarily, communities exposed to digested gluten were enriched in Pseudomonadota. Hence, this study shows a method for culture and stable maintenance of gut communities derived from gluten metabolism. This method enables the analysis of microbial metabolism of gluten in the gut from a community perspective, SI, This research was funded by Junta de Castilla y León, grant number LE015P20, and Ministerio de Ciencia e Innovación, grant PID2020-119044GB-I00. Y.C.M. received a grant from Conserjería de Educación of Junta de Castilla y León, co-funded by the European Social Fund (Orden de 12 de diciembre de 2019)
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease

  • San Martin Bécares, María Isabel
  • Chamizo Ampudia, Alejandro
  • Sanchiz Giraldo, África
  • Ferrero García, Miguel Ángel
  • Martínez Blanco, Honorina
  • Rodríguez Aparicio, Leandro Benito
  • Navasa Mayo, Nicolás
[EN]Intestinal microbiota and the host’s immune system form a symbiotic alliance that sustains normal development and function in the human gut. Changes such as dietary habits among societies in developed countries have led to the development of unbalanced microbial populations in the gut, likely contributing to the dramatic increase in inflammatory diseases in the last few decades. Recent advances in DNA sequencing technologies have tremendously helped to characterize the microbiome associated with disease, both in identifying global alterations and discovering specific biomarkers that potentially contribute to disease pathogenesis, as evidenced by animal studies. Beyond bacterial alterations, non-bacterial components such as fungi, viruses, and microbial metabolites have been implicated in these diseases, influencing immune responses and gut homeostasis. Multi-omics approaches integrating metagenomics, metabolomics, and transcriptomics offer a more comprehensive understanding of the microbiome’s role in disease pathogenesis, paving the way for innovative diagnostic and therapeutic strategies. Unraveling the metagenomic profiles associated with disease may facilitate earlier diagnosis and intervention, as well as the development of more personalized and effective therapeutic strategies. This review synthesizes recent and relevant microbiome research studies aimed at characterizing the microbial signatures associated with inflammatory bowel disease, colorectal cancer, and celiac disease., SI, We acknowledge the received support from the Spanish Ministerio de Ciencia e Innovación, grant number PID2020-119044GB-I00, and by the Junta de Castilla y León, grant number LE015P20.